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Infection of mice with murine cytomegalovirus (MCMV) recapitulates many
physiopathological characteristics of human CMV infection and enables studying the
interactions between a virus and its natural host. Dendritic cells (DC) are mononuclear
phagocytes linking innate and adaptive immunity which are both necessary for MCMV
control. DC are critical for the induction of cellular immunity because they are uniquely
efficient for the activation of naïve T cells during their first encounter with a pathogen. DC
are equipped with a variety of innate immune recognition receptors (I2R2) allowing them
to detect pathogens or infections and to engulf molecules, microorganisms or cellular
debris. The combinatorial engagement of I2R2 during infections controls DC maturation
and shapes their response in terms of cytokine production, activation of natural killer
(NK) cells and functional polarization of T cells. Several DC subsets exist which express
different arrays of I2R2 and are specialized in distinct functions. The study of MCMV
infection helped deciphering the physiological roles of DC subsets and their molecular
regulation. It allowed the identification and first in vivo studies of mouse plasmacytoid DC
which produce high level of interferons-α/β early after infection. Despite its ability to infect
DC and dampen their functions, MCMV induces very robust, efficient and long-lasting
CD8 T cell responses. Their priming may rely on the unique ability of uninfected XCR1+
DC to cross-present engulfed viral antigens and thus to counter MCMV interference
with antigen presentation. A balance appears to have been reached during co-evolution,
allowing controlled replication of the virus for horizontal spread without pathological
consequences for the immunocompetent host. We will discuss the role of the interplay
between the virus and DC in setting this balance, and how advancing this knowledge
further could help develop better vaccines against other intracellular infectious agents.
Keywords: murine cytomegalovirus, plasmacytoid dendritic cells, XCR1+ dendritic cells, type I interferons, cross-
presentation, NK cells, immune evasion, vaccination
INTRODUCTION
Human cytomegalovirus (HCMV) is DNA β-herpes virus
extremely prevalent word wild and establishing a persistent latent
infection in immunocompetent hosts. HCMV infection is gen-
erally asymptomatic even during primary infection. However,
HCMV is an important opportunistic agent causing severe mor-
bidity or death in immunocompromised hosts such as AIDS
patients, fetuses and newborns (Krmpotic et al., 2003). To date,
no vaccine exists against HCMV and designing one is a very active
research field.
Mouse cytomegalovirus (MCMV) is a natural rodent
pathogen, establishing life-long persistent latent infections in
mice. In natura, MCMV is transmitted between mice mostly by
biting or upon contact with feces of infected mice. These routes
of infection are hard to mimic in laboratory. The corresponding
physiological doses of virus inoculum are unknown. Inoculation
of mice with relatively high doses of virus inoculum via the
intra-peritoneal (i.p.) or intravenous (i.v.) routes are the main
experimental models used. These experimental settings are highly
reproducible and allow using many mutant mouse strains or
viruses with reasonably low amounts of animals per group. This
enabled to precisely decipher the cellular and molecular mech-
anisms regulating immune responses to MCMV. A parallel can
be drawn for key pathological features and protection mecha-
nisms between experimental MCMV infection in mice and in
natura HCMV infection in humans. Hence, most of the obser-
vations gathered with experimental MCMV infection in mice
should apply to some extent to in natura immune responses
against MCMV infection in mice and most importantly against
HCMV infection in humans.
During the acute phase of the infection, MCMV can infect
hematopoietic cells including macrophages and dendritic cells
www.frontiersin.org July 2014 | Volume 5 | Article 378 | 1
Alexandre et al. DC subset responses to MCMV infection
(DC) but also many non-hematopoietic cells such as hepato-
cytes, endothelial cells or epithelial cells (Krmpotic et al., 2003).
Both innate and adaptive immunity are required for resistance to
MCMV infection. Amongst innate immune lymphocytes, Natural
Killer (NK) cells are the most critical for defense against MCMV
infection in several mouse strains. Indeed, NK cells can control
MCMV replication by directly recognizing and killing infected
cells, depending on the combined haplotypes of class I major
histocompatibility (MHC-I) genes and NK cell receptor genes
(Miletic et al., 2013). NK T cells (Van Dommelen et al., 2003;
Tyznik et al., 2014) and γδ T lymphocytes (Ninomiya et al., 2000)
can also contribute to innate immune defenses against MCMV
infection. Adaptive humoral immunity mediates protection since
antiviral antibodies efficiently limit viral replication during reac-
tivation from latency (Jonjic et al., 1994) and antibody infusion
can protect both adult and newborn mice from the pathology
induced by MCMV infection (Cekinovic et al., 2008). CD8 T cell
responses are critical for protection not only against acute infec-
tion inmouse strains with inefficient NK cell responses (Lathbury
et al., 1996; Krmpotic et al., 1999) but also for long-term control
of viral replication in all mouse strains by preventing the selection
of innate immunity escape mutants (French et al., 2004, 2005)
and by contributing to prevent viral reactivation from latency
(Polic et al., 1998; Simon et al., 2006). CD4 T cell responses
also play a key role in the pathophysiology of MCMV infec-
tion. During acute infection, antiviral CD4 T cells accumulate
to high levels in the spleen and lungs where they produce both
Th1 and Th17 cytokines (Arens et al., 2008; Walton et al., 2008).
Through their IFN-γ secretion, CD4 T cells directly contribute to
the control of viral replication in various organs (Walton et al.,
2011a; Jeitziner et al., 2013) with a non-redundant role in the
salivary glands (SG) where the functions of the other subsets
of lymphocytes are compromised (Jonjic et al., 1989; Lathbury
et al., 1996; Walton et al., 2011a; Thom et al., 2014). However,
CD4 T cells can also contribute to immunosuppressive effects
including IL-10 production which limits the induction of pro-
tective Th1 responses and promotes prolonged infection of the
SG (Humphreys et al., 2007a; Mandaric et al., 2012). During the
acute phase of the infection, CD4 T cell responses are critical
to promote the induction of humoral immunity but dispensable
for the induction of CD8 T cell responses (Jonjic et al., 1989).
During the latent phase of the infection, CD4 T cell responses pro-
mote the expansion of antiviral CD8 T cells (Humphreys et al.,
2007b; Snyder et al., 2009; Walton et al., 2011b). The activation
of both NK and CD8 T cells heavily relies on their cross-talk
with DC and many studies have investigated the underlying cel-
lular and molecular mechanisms, including the role of specific
DC subsets and/or specific DC functions. In contrast, much less
is known on the interactions between DC and NK T cells, δγ
T cells, CD4 T cells or B lymphocytes during MCMV infection.
Hence, since our review is focused on the role of DC subsets dur-
ing MCMV infection, we will discuss their impact on NK and
CD8 T cell responses but not elaborate much on the functions
of other lymphocyte populations. Specifically, we will develop the
hypothesis that the interplay between DC and MCMV is critical
in setting a delicate but mutually beneficial balance between the
virus and its host. The health of the host is preserved despite the
infection by two complementary mechanisms. First, viral repli-
cation and cytopathic effects are efficiently controlled in most
organs by DC-dependent NK and CD8 T cell responses. Second,
negative regulation of immune responses induced both by host
feedback mechanisms and by virus manipulation of host cells
prevents the development of severe immunopathology. The life
cycle of the virus can be completed through establishment of
latency and horizontal transfer to other hosts. We will discuss
how viral immunoevasion genes and host professional cross-
presenting XCR1+ DC play a key role in setting this balance,
in particular by promoting the induction of protective inflation-
ary effector memory CD8 T cell responses. This characteristic of
adaptive immune responses to CMV infections is being used to
help develop better vaccines against other intracellular infectious
agents, notably Human Immunodeficiency Virus (HIV).
A CURRENT SIMPLIFIED VIEW ON DC SUBSET
NOMENCLATURE AND FUNCTIONAL SPECIALIZATION
DC are rare heterogeneous mononuclear phagocyte cells of the
immune system which are characterized by their unique ability
to activate naïve T lymphocytes. DC can be classified in five
main subsets mainly based on differences in their ontogeny and
functions (Table 1) (Dalod et al., 2014). Plasmacytoid DC (pDC)
and the two subsets of conventional DC (cDC): CD8α+-type
DC and CD11b+ DC, share the same developmental pathway.
They strongly depend on the growth factor FLT3-L for their
differentiation and homeostasis. They derive from a proximal
common hematopoietic progenitor, the common DC progenitor
(CDP), which is devoid of any other differentiation poten-
tial. In contrast, Langerhans cells (LC), which are exclusively
found in the epidermis, and monocyte derived DC (MoDC),
which develop only during inflammation, belong to the mono-
cytic lineage. Mouse pDC can be unequivocally identified as
CD11b−CD11cint and Bst2hi or SiglecH+. They are specialized
in rapid and high level production of the antiviral cytokines
type I interferon (IFN-I), including during MCMV infection
(Table 1). CD8α+-type DC and CD11b+ DC exist both as
lymphoid tissue-resident DC (LT-DC) and as sentinel immune
cells surveying all non-lymphoid tissues and migrating to their
draining lymph nodes upon activation (MigDC). CD11b+ cDC
are identified as Lineage−CD11c+/highLy6C−CD64−MerTK−
cells, to distinguish them from macrophages which express
MerTK and from MoDC which derive from Ly6Chi (classical)
monocytes and are Ly6G−CD11b+CCR2+CD64lowMerTK−
(Tamoutounour et al., 2013). CD8α+-type cDC can be identified
as Lineage−SiglecH−CD11b−CD11c+/high and either CD8α+,
CD207+, CD24+ or CD103+ depending on the tissues and
mouse strains examined. CD11b+ cDC are most efficient for
CD4 T cell priming, in particular their polarization toward Th2
or Th17, and for the promotion of humoral immunity. They
are considered to play a critical role in immune defenses against
extracellular pathogens. CD8α+ cDC are most efficient for CD8
T cell priming, in particular through uptake and processing
of exogenous antigens for their presentation in association
with MHC-I molecules, a process called cross-presentation.
CD8α+-type cDC are critical for immune defenses against
cancer and against a variety of intracellular pathogens including
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Table 1 | Nomenclature, phenotype and in vivo functions of monocyte and DC subsets during MCMV infection.
Name Markers Functions during MCMV infection References
Infection* Innate immunity Adaptive Immunity
XCR1+ cDC** Lin− CD11b− CD11chigh XCR1+
CD24+ CD8α+/− CD103+/−
Yes, <5% IL-12, IL-15 . . . NK cell
activation
Priming of antiviral
CD8 T cells in acute
infection
Andrews et al., 2003; Dalod
et al., 2003; Torti et al., 2011b;
Busche et al., 2013
CD11b+ cDC Lin− CD64− MerTK−CD11chigh
CD11b+
Yes, <<1% IL-12, IL-15 . . . NK cell
activation
Control of CD4 T cell
priming?
Dalod et al., 2003; Andoniou
et al., 2005
pDC Lin− CD11b− CD11cint Bst2+
SiglecH+
No IFN-I, IL-12, TNF, CCL3
. . . NK cell activation
Dispensable? Asselin-Paturel et al., 2001;
Dalod et al., 2002, 2003; Krug
et al., 2004; Scheu et al., 2008;





Lin− MerTK− CD11b+ Ly6Chigh
CCR2+ CD64+/low
No iNOS, TNF, IL-15? . . .
recruitment in the liver




Daley-Bauer et al., 2012;






the virus, promotion of
latent infection
? ? Daley-Bauer et al., 2014
LC Lin− CD11c+ CD24+ CD11b+
CD207high
No ? ?
*In vivo viral infection of DC or monocyte subsets in mice challenged i.p. with MCMV.
**The name XCR1+ cDC is not yet an official nomenclature but has been coined here to define in a simple and general way all the CD8α+-type cDC of the mouse.
***Studies do not always rigorously discriminate between activated classical monocytes, myeloid-derived suppressor cells (MDSC) and MoDC, which are therefore
discussed together here.
?Contribution unknown.
MCMV (Table 1). Gene expression profiling and functional
analyses have established homologies between mouse and human
DC subsets, including between mouse CD8α+-type cDC and
human CD141(BDCA3)+ cDC which both specifically express
the chemokine receptor XCR1(Dorner et al., 2009; Bachem
et al., 2010; Crozat et al., 2010, 2011). Hence, to promote a
simple and universal DC subset nomenclature, in this review
CD8α+-type cDC will be coined XCR1+ cDC. MoDC constitute
only one of the differentiation fates of classical monocytes
upon activation. Classical monocytes can also differentiate into
inflammatory macrophages and myeloid-derived suppressor
cells. It is not easy, and rarely achieved, to rigorously discrim-
inate between activated classical monocytes, inflammatory
macrophages, myeloid-derived suppressor cells and MoDC. The
reader should keep this issue in mind when we will discuss the
role of these cells in MCMV infection. Not much is known
about the role of LC in vivo during MCMV infection. Hence,
most of this review will focus on the role of pDC, cDC, and to
some extent monocytes subsets and MoDC/activated classical
monocytes/myeloid-derived suppressor cells.
ROLE OF DC AND MONOCYTES IN MCMV REPLICATION AND
DISSEMINATION
WHAT ARE THE FIRST CELLS INFECTED BY MCMV IN VIVO?
MCMV has a broad tropism. It can infect a variety of cell types
in vivo, including neutrophils and many cells of the mononuclear
phagocyte system (Krmpotic et al., 2003). Several studies analyzed
the kinetics of MCMV replication and dissemination early after
i.p. inoculation. Replicative virus is found in most visceral organs
1 week after infection. However, it needs cellular vehicles to dis-
seminate in distal organs, in particular the SG, and to remain
latent. To examine MCMV tropism in vivo at different times after
i.p. infection, several studies used the same recombinant MCMV
expressing the enhanced green fluorescent protein (EGFP) under
control of the native immediate-early 1/3 promoter (Henry et al.,
2000). In these experimental settings, among splenic DC subsets,
XCR1+ DC were preferentially infected at 36–48 h after MCMV
infection albeit at a very low frequency (∼2–5% EGFP+) (Dalod
et al., 2003). EGFP+ cells could be detected in several other
hematopoietic cell types, prominently neutrophils (∼15–20%
EGFP+), also NK cells (3–7%) but not much B and T cells
(<2%) (Banks et al., 2005; Benedict et al., 2006). However, viral
replication occurred preferentially in non-hematopoietic, stro-
mal, cells which constituted most of the source of viral RNA
in the spleen at 3 days after infection (Benedict et al., 2006).
Indeed, in the spleen, MCMV first infects stromal cells (ER-
TR7+CD29+), in themarginal zone, at 6–8 h after inoculation. By
17 h, MCMV has disseminated in the red pulp, and by 48 h to the
white pulp including in DC (Hsu et al., 2009). Hence, endothe-
lial or fibroblastic stromal cells are the first targets infected by
MCMV in vivo. They constitute the bulk of MCMV replicat-
ing cells in the spleen at all time points examined during acute
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infection of immunocompetent mice. A small proportion of dif-
ferent hematopoietic cell types is also infected in vivo relatively
early after virus inoculation, including DC.
ARE DC OR MONOCYTES PLAYING A SIGNIFICANT ROLE IN MCMV
REPLICATION AND DISSEMINATION?
Splenectomized mice harbored decreased viral replication in
the liver and increased survival upon acute MCMV infection
(Katzenstein et al., 1983). Hence, the spleen appears to be an
important site of MCMV replication early after systemic inocu-
lation of MCMV and to promote dissemination to other organs.
This suggests that specific populations of immune cells are essen-
tial to initiate MCMV infection and to promote its dissemination
to the spleen and then throughout the body early after systemic
inoculation of the virus, as was shown of XCR1+ DC for systemic
infection with Listeria monocytogenes (Neuenhahn et al., 2006;
Edelson et al., 2011). However, much remains to be done to eval-
uate the contribution of different subsets of DC or monocytes to
MCMV replication and dissemination.
Contribution of DC and monocyte subsets to viral replication and
spread across tissues during acute infection
To advance understanding of the mechanisms promoting MCMV
dissemination in vivo, the group of Koszinowski has recently engi-
neered a mutated strain of MCMV allowing to measure what
fraction of the virus has been replicating in a given cell type
(Sacher et al., 2008b). This “cell tropism-trap” MCMV encodes
for a conditional reporter cassette consisting in the sequence cod-
ing for EGFP under the control of the HCMV major immediate-
early promoter but downstream of a floxed transcriptional stop
sequence. In the absence of expression of the Cre recombinase in
infected cells, the viral progeny will remain unstained. However,
after infection of a cell expressing Cre, the viral genome will
have deleted the floxed stop sequence. All the cells consecutively
infected by this virus progeny will be green. Thus, this system
uniquely allows measuring the specific contribution of virtually
any cell type to viral dissemination in vivo, by directly analyz-
ing the fraction of EGFP-expressing virions in different organs at
different times after infection. In CD11c-Cre transgenic mice, a
considerable amount of EGFP+ virus was found in most organs.
Thus, an important fraction of the virus has replicated in vivo at
some time point in CD11c+ cells, likely in cDC (Sacher et al.,
2008a). This observation supports the hypothesis that cDC may
bear an important contribution to viral replication and spread
across tissues during acute infection. Whether this phenomenon
is necessary or redundant for the initiation of the infection or
for viral dissemination across organs is unknown. To answer
this question, it will be necessary to measure the impact of DC
depletion at different times after infection on the viral load in
different tissues. This could be achieved by using mice allowing
conditional elimination of ZBTB46+ cells upon in vivo injec-
tion of diphtheria toxin (Meredith et al., 2012). It would also
be interesting to define more precisely which subsets of CD11c+
cells contribute the most to MCMV replication in vivo. Among
DC subsets, XCR1+ DC are preferentially infected by MCMV at
36–48 h after challenge (Dalod et al., 2003). However, XCR1+ DC
isolated from the spleen at 18 h after challenge do not produce
infectious virus contrary to CD11b+ DC (Busche et al., 2013).
Viral titers are unaffected in the spleen and liver of Batf3−/− mice,
despite their lack of XCR1+ DC under steady state conditions
(Torti et al., 2011b). This does not completely rule out a role of
XCR1+ DC in viral dissemination, because inflammatory condi-
tions promote redundancy in transcription factor expression and
functions in the DC lineage, allowing Batf3-independent develop-
ment of XCR1+ cDC (Tussiwand et al., 2012; Seillet et al., 2013)
which has not been examined in MCMV infection. Moreover,
in the rat model of CMV infection, the virus encodes for an
XCR1 ligand which exclusively binds and attracts XCR1+ DC
(Geyer et al., 2014). Hence, it would be interesting to rigorously
address what is the contribution of XCR1+ DC to MCMV repli-
cation in vivo. This could be achieved by infecting Xcr1-Cre mice
with the “cell tropism-trap” MCMV, or by evaluating the impact
of XCR1+ DC depletion on MCMV spread to different tissues.
Likewise to all mutant viruses engineered from the parental BAC
pSM3fr MCMV, the “cell tropism-trap” MCMV bears a mutation
in theMCK-2 ORF leading to expression of a truncated, nonfunc-
tional, viral MCK-2 chemokine (Mitrovic et al., 2012a). MCK-2
attracts myeloid cells and participates to MCMV dissemination
in vivo in particular to the SG (Fleming et al., 1999; Saederup
et al., 2001). Thus, the in vivo dissemination of the “cell tropism-
trap” MCMV must be altered. Therefore, it would be important
to engineer an MCK-2-repaired “cell tropism-trap” MCMV for
future studies.
Role of DC and monocyte subsets for viral dissemination to salivary
glands and for establishment of latency
After footpad inoculation of MCMV, the viral chemokineMCK-2
recruits non-classical (CX3CR1hi patrolling) monocytes to infec-
tion site where they become infected. These cells then serve as
immune vehicles to disseminate the virus to distal organs, espe-
cially to the SG. Non-classical monocytes are also essential for
the establishment of latent infection (Daley-Bauer et al., 2014).
However, this does exclude a contribution of DC subsets or other
cell types to this process.
DC ABILITY TO INDUCE PROTECTIVE ANTIVIRAL CD8 T CELL
RESPONSES IS DIFFERENTIALLY IMPACTED BY IN VITRO vs.
IN VIVO INFECTIONS
MCMV encodes for many immune evasion genes, including some
genes compromising MHC-I antigen presentation by infected
cells. However, contradictory reports have been published regard-
ing the ability of the virus to paralyze DC functions. We will
discuss how these reports could be reconciled by taking into
account differences in the interactions between MCMV and DC
in vitro vs. in vivo (Figure 1).
IN VITRO INFECTION OF DC BY MCMV COMPROMISES THEIR ABILITY
TO INDUCE ANTIVIRAL ADAPTIVE IMMUNITY
DC lines or MoDC derived in vitro in GM-CSF bone marrow
cultures have been extensively used to investigate the interac-
tions between MCMV and DC (Andrews et al., 2001; Mathys
et al., 2003; Loewendorf et al., 2004; Mintern et al., 2006;
Benedict et al., 2008). These studies showed that DC are per-
missive to MCMV in vitro, and that infected DC are relatively
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FIGURE 1 | DC functions are differentially impacted by their infection
in vitro vs. the infection of mice in vivo. (A) Impact on DC functions of
their infection by MCMV in vitro. In vitro, MCMV-infected DC are “paralyzed”
by the virus which prevents them to deliver adequate signals 1 and 2 for
antiviral CD8 T cell activation. Specifically, infected DC down-regulate their
expression of MHC-I and activating co-stimulation (CD40, CD80, CD86)
molecules as a consequence of their expression of viral immune evasion
genes. They induce inhibitory co-stimulation molecules (PD-L1 and PD-L2).
Hence, infected DC only weakly prime antiviral CD8 T cells. (B) cDC
functions in vivo in MCMV-infected mice. cDC are very strongly activated by
MCMV infection in vivo, in a way enabling them to induce potent T cell
activation in vitro, and consistent with the fact that MCMV infection induces
very strong and protective antiviral cellular immune responses in vivo.
Specifically, XCR1+ DC and CD11b+ cDC strongly up-regulate MHC and
activating co-stimulation molecules in vivo, and can also produce T
cell-activating cytokines such as IL-12 and IL-15. (C,D) Proposed explanations
to the discrepancy of the impact of MCMV infection on DC in vitro vs. in vivo.
(C) Impact of the nature of DC subsets and of their frequency of infection.
The DC used in vitro are derived from monocytes (MoDC) and strongly differ
from the DC involved in vivo in the induction of anti-viral immune responses
in lymphoid tissues (LT-DC). High MOI are used for in vitro infection of DC,
leading to a very high proportion of infected cells subjected to the effects of
viral immune evasion genes. In contrast, only a very small fraction of XCR1+
cDC and CD11b+ cDC is infected in vivo. (D) Protective functions of cDC in
MCMV infected mice are promoted by the inflammatory milieu, in particular
by IFN-I and IFN-γ, and by cross-talk with other immune cells.
poor activator of T cells (Andrews et al., 2001; Mathys et al.,
2003; Benedict et al., 2008) (Figure 1A). A variety of viral
immune evasion genes affect the delivery by infected DC to
T cells of all the three types of signals necessary for their
priming. Signal 1 corresponds to the triggering of the T cell
receptor by viral peptide-MHC-I complexes. Signal 2 corre-
sponds to the triggering of activating co-stimulation receptor
such as CD28 or CD27 by the CD80/86 and CD70 co-stimulation
molecules induced on mature DC. Signal 3 corresponds to
cytokines which can contribute to promote the proliferation
of T cells and instruct their differentiation toward specific
functions.
Inhibition of signal 1 delivery to T cells: inhibition of antigen
processing and presentation in DC infected by MCMV in vitro
DC infected in vitro by MCMV have lower expression of
MHC-I and MHC-II molecules at their surface as compared to
non-infected DC (Andrews et al., 2001; Benedict et al., 2008)
(Figure 1A). Three MCMV genes have been identified to regu-
late MHC-I expression on infected cells and DC: m04, m06, and
m152, collectively called MHC-I immune evasion genes. These
three genes inhibit the transport of MHC-I molecules to the cell
surface, but also block the transporter associated with antigen
processing machinery. This leads to a drastic reduction of cell
surface expression of viral peptide-MHC-I complexes on infected
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DC and therefore to a strong impairment of their ability to deliver
signal 1 for the activation of antiviral CD8 T cells (Hengel et al.,
1999).
Modulation of signal 2 delivery to T cells: inhibition of the
expression of activating co-stimulation molecules and induction of
the expression of inhibitory co-stimulation molecules on DC
infected by MCMV in vitro
The viral m147.5 gene specifically blocks cell surface export of
CD86 and m138 blocks CD80 (Loewendorf et al., 2004; Mintern
et al., 2006). These MCMV genes do not affect globally the secre-
tory pathway of infected cells, because cell surface export of
other molecules is not affected. In DC infected in vitro, m138
co-localizes with CD80 in lysosomes, suggesting a direct inter-
action between these two molecules leading to a redirection of
the intracellular trafficking of CD80 (Mintern et al., 2006). The
viral m155 gene inhibits CD40 expression on in vitro infected DC,
possibly by inhibit the translation of Cd40 mRNA (Loewendorf
et al., 2011). As a result, DC infected in vitro by MCMV express
low amounts of the activating co-stimulation molecules CD40,
CD80, and CD86 (Figure 1A). Infected DC also up-regulate the
inhibitory co-stimulation molecules PD-L1 and PD-L2 (Andrews
et al., 2001; Mathys et al., 2003; Benedict et al., 2008). Thus,
in vitro infection of DC by MCMV biases the nature of the signal
2 that they deliver to CD8 T cells toward inhibition (Figure 1A).
Modulation of signal 3 delivery to T cells: how does in vitro
infection of DC by MCMV impact their cytokine production?
Little is known about the role of viral immune evasion genes
in modulating DC cytokine responses. A study on infected
macrophages showed that the viral ie1 gene blocks their capac-
ity to produce TNF through a pathway independent of NFKB
(Rodriguez-Martin et al., 2012). The viral m45 gene blocks the
NFKB pathway in infected fibroblast, resulting in a loss of TNF
production (Mack et al., 2008). The m45 gene also blocks TLR3
signaling in infected fibroblasts (Mack et al., 2008). It is possible
that in vitro infection of DC by MCMV also affects their expres-
sion of cytokines, to prevent the delivery of an activating signal
3 to antiviral CD8 T cells or even to induce the release of an
inhibitory signal 3 such as IL-10 (Figure 1A).
THE IMMENSE MAJORITY OF DC FROMMCMV INFECTED MICE
UNDERGO A STRONG IMMUNOGENIC MATURATION AND ARE
COMPETENT FOR THE INDUCTION OF ANTIVIRAL ADAPTIVE
IMMUNITY
In contrast to what is observed upon in vitro infection of DC lines
or MoDC, mouse splenic DC subsets undergo a strong immuno-
genic maturation in vivo in the spleen between 36 and 48 h after
infection (Figure 1B). This was shown through measurements of
different parameters, including their expression of cytokines and
of MHC and co-stimulation molecules (Dalod et al., 2002, 2003;
Delale et al., 2005; Zucchini et al., 2008a; Baranek et al., 2012), by
gene expression profiling studies (Baranek et al., 2012; Vu Manh
et al., 2013), and by functional assays (Dalod et al., 2003). DC iso-
lated ex vivo after MCMV infection activate more efficiently naïve
CD8 T cells as compared to DC isolated from non-infected mice,
likely due to their activation state (Dalod et al., 2003) (Figure 1B).
Competence of DC isolated from MCMV-infected mice for signal 1
delivery to T cells
CD11b+ DC isolated from infected C57BL/6 mice are produc-
tively infected and fail to activate naïve anti-MCMV CD8 T cells
in ex vivo culture, suggesting that productive MCMV infection
of CD11b+ DC in vivo compromises their ability to directly pro-
cess and present endogenously synthesized viral antigens to CD8
T cells (Busche et al., 2013). However, most splenic DC strongly
up-regulate MHC-I (Figure 1B) and MHC-II molecules at their
surface early after MCMV infection (Dalod et al., 2003; Delale
et al., 2005). In addition, XCR1+ DC isolated from infected mice
efficiently present in vivo acquired MCMV antigens to CD8 T
cells (Busche et al., 2013). Thus, contrary to in vitro infected
DC lines or MoDC, a significant fraction of LT-DC isolated from
MCMV-infected mice is competent for signal 1 delivery to T cells
(Figure 1B).
Competence of DC isolated from MCMV-infected mice for
activating signal 2 delivery to T cells
During MCMV infection, most splenic DC strongly up-regulate
CD40, CD80, and CD86 at their surface (Figure 1B) (Dalod
et al., 2003; Delale et al., 2005). In addition, DC subsets iso-
lated from infected mice and pulsed ex vivo with optimal epitopic
peptides better activate cognate CD8 T cells than DC isolated
from uninfected animals (Dalod et al., 2003). Thus, contrary to
in vitro infected DC lines orMoDC, LT-DC isolated fromMCMV-
infected mice are competent for signal 2 delivery to T cells.
Even though splenic DC from infected mice do up-regulate the
inhibitory co-stimulation molecule PD-L1 (Figure 1B) (Baranek
et al., 2012; VuManh et al., 2013), this does not appear to strongly
impact on their ability to activate antiviral CD8 T cells. Indeed,
in vivo blockade of PD1 only marginally increases antiviral CD8
T cell responses which are already very robust in the absence of
treatment (Benedict et al., 2008).
Competence of DC isolated from MCMV-infected mice for signal 3
delivery to induce protective T cell functional polarization
Many innate cytokines and chemokines are produced early after
MCMV infection in vivo, around 36 h after challenge (Ruzek et al.,
1997), including IFN-I, IL-15, and IL-12 which are critical for
antiviral defense (Orange and Biron, 1996a,b; Presti et al., 1998;
Nguyen et al., 2002; Strobl et al., 2005; Baranek et al., 2012).
The receptor for IFN-I is expressed ubiquitously and it is likely
that the main function of IFN-I is to induce cell-intrinsic antivi-
ral effector molecules in uninfected cells to enable them to resist
MCMV infection. The nature of IFN-I induced genes conferring
cell-intrinsic immunity to MCMV is unknown. Of note, MCMV
encodes for an immune evasion gene inhibiting IFN-I and IFN-γ
responses in infected cells by targeting the downstream signaling
molecule STAT2 (Zimmermann et al., 2005). However, IFN-I also
mediates immunoregulatory functions which are critical for the
control of MCMV infection. More than a decade ago, the study
of MCMV infection allowed the identification and first in vivo
studies of mouse pDC, by demonstrating that they are the major
producers of IFN-I early after infection (Asselin-Paturel et al.,
2001; Dalod et al., 2002). This has since been confirmed by sev-
eral independent studies (Krug et al., 2004; Scheu et al., 2008;
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Swiecki et al., 2010). More generally, during MCMV infection,
a fraction of splenic DC produce IFN-I, IL-12, and IL-15 (Dalod
et al., 2002, 2003; Zucchini et al., 2008a; Vu Manh et al., 2013).
Hence, DC isolated fromMCMV-infected mice are competent for
signal 3 delivery to induce protective T cell functional polarization
(Figure 1B).
HOW TO EXPLAIN THE DISCREPANCY OF THE IMPACT OF MCMV
INFECTION ON DC IN VITRO vs. IN VIVO?
Several factors can contribute to the discrepancy of the impact of
MCMV infection on DC in vitro vs. in vivo (Figures 1C,D).
The DC subsets generally used for in vitro studies are different from
LT-DC
The DC subsets generally used for in vitro studies belong to the
monocyte lineage and are not equivalent to the LT-DC subsets
responsible for the induction of adaptive immunity in secondary
lymphoid organs (Figure 1C) (Robbins et al., 2008). Hence, these
in vitro models might not faithfully represent the in vivo inter-
play between MCMV and DC. Indeed, it was recently shown
that, upon infection with MCMV in vitro, MoDC but not FLT3-
L DC fail to produce IL-12 and to activate NK T cells, while
both uninfected DC subsets are able to produce the cytokine
upon stimulation with a synthetic TLR9 ligand (Tyznik et al.,
2014). Spleen DC subsets exposed to MCMV in vitro produce
IL-12 (Krug et al., 2004) likewise to their in vitro derived FLT3-
L DC counterparts and contrary to MoDC. These observations
suggest that some of the differences observed regarding the con-
sequences of DC exposure to MCMV in vitro vs. in vivo might
result from different cell-intrinsic properties of MoDC and LT-
DC, includingmaybe a higher susceptibility of the former to some
of the effects of the virus immunoevasion genes. Hence, it will
be interesting to examine whether MCMV infection differentially
affect in vivo DC from the monocytic lineage, namely LC and
MoDC, as compared to LT-DC. However, as seen with DC lines
or MoDC, LT-DC isolated from uninfected mice and exposed
in vitro to MCMV do show a strong impairment in their induc-
tion of activating co-stimulation molecules, strongly up-regulate
inhibitory co-stimulation molecules, and fail to efficiently acti-
vate antiviral CD8 T cells in vitro as well as upon in vivo transfer
(Benedict et al., 2008; Busche et al., 2013). Hence, it is likely that
the LT-DC infected by MCMV in vivo are paralyzed or even exert
immunosuppressive functions (Figure 1C). Thus, additional fac-
tors must account for the ability of LT-DC to evade in vivo the
immunosuppressive functions of MCMV.
Only a very small fraction of DC are infected by MCMV in vivo and
hence potentially susceptible to the action of viral immune evasion
genes
High MOI are used for in vitro infection of DC, leading to a very
high proportion of infected cells paralyzed or polarized toward
immunosuppressive functions due to cell-intrinsic effects of viral
immune evasion genes (Figure 1C). This may also lead to a strong
dominant negative effect of these infected DC over the action
of the few uninfected immunogenic DC eventually present in
the culture (Figure 1C). In contrast, in vivo, in tissues, the ratio
of the numbers of infectious viral particles to the numbers of
DC is low (low MOI) (Figure 1C). Moreover, the probability of
encounter between the virus and DC in vivo is lower due to the
complexity of the tissue environment. Indeed, only a very small
fraction of XCR1+ cDC and CD11b+ cDC is infected in vivo
(Figure 1C). pDC are not infected. The first study that had exam-
ined the impact of MCMV infection on DC in vivo claimed that a
major fraction of the splenic DC is infected and that this leads to a
global paralysis of DC functions (Andrews et al., 2001). However,
all of the other studies that have since examined MCMV tropism
for DC in vivo reported that only a very minor fraction—a few
percent—of splenic DC are infected at any time point after chal-
lenge (Dalod et al., 2003; Banks et al., 2005; Benedict et al., 2006;
Mitrovic et al., 2012a). Moreover, all these later studies concur
that DC are strongly activated byMCMV infection in vivo in a way
enabling them to induce potent T cell activation in vitro, and con-
sistent with the fact thatMCMV infection induces very strong and
protective antiviral cellular immune responses in vivo. However,
CD11b+ cDC isolated from the spleen of infected mice produce
infectious viral particles and fail to activate antiviral CD8 T cells
ex vivo, unless they are exogenously loaded with synthetic viral
epitopic peptides (Busche et al., 2013). Moreover, most of the DC
infected by MCMV in vivo do not produce detectable levels of
activation cytokines, not only IFN-I but also IL-12 (Dalod et al.,
2003). This suggests that the cDC that are infected by MCMV
in vivo are “paralyzed” by the virus at least for antigen processing
and presentation, and for T-cell activating cytokine production,
i.e., for signal 1 and 3 delivery (Figure 1C). The expression of co-
stimulation molecules (signal 2) on the DC infected by MCMV
in vivo has not yet been reported. The consequences on the
functions of XCR1+ DC of their infection in vivo are not clear,
although it may not result in the production of infectious virus
(Busche et al., 2013). It would be interesting to purify infected
(EGFP+) and non-infected (EGFP−) splenic DC subsets from
the same mice and examine their gene expression profiling in
order to get an unbiased and global view of how the infection
of DC in vivo modulates their biology. In any case, in vivo, most
DC are not infected and thus not susceptible to the cell-intrinsic
action of viral immune evasion genes. In addition, there is no
dominant negative effect of the DC that are eventually paralyzed
or polarized toward immunosuppressive functions due to their
infection by MCMV. On the contrary, in vivo, most of the DC are
uninfected, mature and immunogenic (Figure 1C).
Protective functions of DC in MCMV infected mice are promoted by
the inflammatory milieu and by cross-talk between different
immune cell types
Other major factors likely contributing to explain the discrep-
ancy of the impact of MCMV infection on DC in vitro vs. in vivo
are differences in the microenvironment in which the interaction
between the virus and the DC is taking place. We will discuss in
particular the role of the inflammatory milieu and of cross-talk
with other immune cell types in promoting protective functions
of DC in MCMV infected mice (Figure 1D).
Role of cell intrinsic responses of DC to IFN-I in promoting pro-
tection against MCMV infection. Mice deficient for the alpha
chain of the receptor for IFN-I (IFNAR) harbor a 7-fold increase
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in the fraction of infected DC, showing that IFN-I efficiently
protects DC from MCMV infection in vivo (Dalod et al., 2003).
Moreover, IFN-I also strongly promotes the maturation of DC
subsets during MCMV infection in vivo, since splenic DC iso-
lated from IFNAR−/− mice show a drastic impairment in their
induction of MHC-I and activating co-stimulation molecules
(Dalod et al., 2003), which is due to cell-intrinsic IFN-I responses
in DC (Baranek et al., 2012) (Figures 1D, 2A). More gener-
ally, cell-intrinsic effects of IFN-I in DC strongly contribute to
drive their broad gene expression reprogramming during MCMV
infection, and are essential to promote protection against dis-
ease and death, while it is not the case in NK cells (Baranek
et al., 2012). It is not yet known precisely what protective func-
tions of DC are promoted by IFN-I during MCMV infection,
in which DC subset, and how. These questions should be pos-
sible to address in the near future by studying the impact of
conditional genetic inactivation of IFNAR in specific DC sub-
sets, as can be achieved by crossbreeding IFNAR-floxed mice
with mice expressing the Cre recombinase in a specific DC
subset.
Role of NK cell responses in preserving DC numbers and
functions during MCMV infection. Mice that fail to control
early replication of MCMV due to lack of efficient antivi-
ral NK cell activity show a dramatic decrease in the num-
bers of XCR1+ DC in the spleen (Andoniou et al., 2005;
Robbins et al., 2007; Mitrovic et al., 2012a). Hence, NK cell
activity contributes to preserve DC homeostasis and likely pro-
motes protective DC functions in vivo during MCMV infec-
tion. This is likely due in part to indirect effects linked
to efficient early control of viral replication (Robbins et al.,
2007) but it may also involve a direct cross-talk between
NK cells and XCR1+ DC which remains to be examined
(Figure 1D). In addition, NK cell delivery of IFN-γ to DC
also likely contributes to promote their maturation (Figure 1D),
not only for MHC-II expression but also potentially for IL-12
production.
In conclusion, in vitro studies have been useful to dissect the
interplay between MCMV and DC (Figure 1A), but it should
be paid attention that, in vivo, most DC are not infected, are
mature, and are competent for ex vivo activation of CD8 T
cells (Figures 1B–D). Hence, it is now quite clear that there is
no induction of global DC functional paralysis by MCMV in
vivo. The small fraction of the DC that are infected by MCMV
does not exert strong dominant immunosuppressive functions
in vivo. They may only slightly reduce the activation of CD8
T cells due to their expression of the inhibitory co-stimulation
molecule PD-L1 (Benedict et al., 2008). MCMV infection very
potently activates DC in vivo, in part due to the induction
of high levels of IFN-I which promote DC maturation and
protective functions against disease and death. It is likely that
this remarkable activation of DC in vivo by MCMV bears a
significant contribution to the balance that has been reached
between this virus and its host during millions of years of co-
evolution, to preserve health in immunocompetent hosts while
still allowing establishment of viral latency and horizontal virus
transfer.
FIGURE 2 | Molecular mechanisms regulating DC subset activation
during MCMV infection. (A) Mechanism promoting DC subset maturation
in vivo during MCMV infection. High amount of IFN-I are produced in vivo by
pDC early after MCMV infection, which drives broad cell-intrinsic responses
in all DC, including canonical DC maturation, promoting protective crosstalk
with innate and adaptive immune cells. (B) Mechanisms promoting pDC
sensing of MCMV infection. Early after completion of the first cycle of virus
replication in vivo, pDC sense MCMV nucleotide sequences via endosomal
TLRs, which leads to innate cytokine production, in particular IFN-I. How
MCMV material ends up in the endosomes of pDC is still not understood.
pDC might specifically recognize and engulf materials derived from infected
cells and containing viral nucleic acids, either apoptotic bodies or exosomes
(➊). pDC may also be able to detect and engulf MCMV particles released by
infected cells or even from the viral inoculum (➋). Finally, pDC may directly
sense and nibble infected cells (➌).
MOLECULAR MECHANISMS REGULATING DC SUBSET
SENSING OF, AND CYTOKINE PRODUCTION IN RESPONSE
TO, MCMV
ROLE OF TOLL-LIKE RECEPTORS IN MCMV SENSING BY DC SUBSETS
The peak of systemic production of IFN-I and IL-12 occurs
between 30 and 48 h after MCMV infection. pDC are the main
producers of these cytokines (Figure 1D) (Dalod et al., 2002;
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Zucchini et al., 2008a), although they are not infected (Dalod
et al., 2003). IFN-I and IL-12 production, and more generally
immune defenses against MCMV infection in vivo, are compro-
mised in mice deficient for Toll-like receptor 9 (TLR9) or for
the downstream signaling adaptor MyD88, as well as to a lesser
extent in mice deficient for TLR3 or for the downstream signaling
adaptor TRIF (Krug et al., 2004; Tabeta et al., 2004; Delale et al.,
2005; Zucchini et al., 2008b). Indeed, pDC sensing of MCMV
infection is completely dependent on MyD88, with a major con-
tribution of TLR9 but a partial redundancy with TLR7 (Krug
et al., 2004; Tabeta et al., 2004; Delale et al., 2005; Zucchini et al.,
2008b). TLR9 recognizes unmethylated CpG DNA sequences that
are absent in the genome of mammals. TLR7 recognizes single
stranded RNA and TLR3 double stranded RNA. TLR3, 7, and 9
are located in endosomes and are thus not exposed to host nucleic
acids. Hence, MCMV sensing by pDC must require active cap-
ture and endocytosis of viral particles or materials derived from
infected cells (Figure 2B).
SOURCES AND MODE OF DELIVERY OF MCMV-DERIVED NUCLEIC
ACIDS TO pDC
How pDC detect the virus before its entry in the endosomal com-
partment is poorly understood and could occur through distinct
but not necessarily exclusive mechanisms (Figure 2B). It is likely
that, in vivo, pDC recognize and engulf apoptotic bodies or exo-
somes released by MCMV-infected cells, (Figure 2B, ➊), as was
demonstrated for other viruses (Dreux et al., 2012) or tumor cells
(Bastos-Amador et al., 2012). pDC could also directly recognize
and engulf viral particles (Figure 2B, ➋). It is also possible that
direct transfer of viral material occurs from live infected cells to
pDC, through cell-cell contacts (Figure 2B,➌), including by nib-
bling of the infected cells by pDC as shown in vitro in co-cultures
of human pDC and HSV-1-infected MoDC (Megjugorac et al.,
2007). The I2R2s allowing pDC to recognize and/or engulf viral
particles or material from infected cells are still unknown. Their
identification is under intensive investigation. The endocytic C-
type lectin receptor SiglecH, which was considered as a likely
candidate, is dispensable for this function (Puttur et al., 2013).
MODULATION OF DC SUBSET RESPONSES DURING MCMV INFECTION
BY OTHER I2R2s
During MCMV infection, several I2R2s modulate DC cytokine
production positively or negatively. SiglecH inhibits IFN-I pro-
duction during MCMV infection in vivo and can inhibit pDC
IFN-I production upon exposure toMCMV in vitro (Blasius et al.,
2006). However, a large part of the inhibitory effect of SiglecH
on IFN-I production in vivo during MCMV infection occurs in
other cells than pDC (Swiecki et al., 2014). Moreover, although
SiglecH−/− mice show significant increases in their systemic lev-
els of IFN-I during MCMV infection, this does not impact on
the control of viral replication and on morbidity or death (Puttur
et al., 2013). Contrary to SiglecH, the C-type lectin Ly49Q pro-
motes higher production of IFN-I by pDC during exposure to
MCMV in vitro, through recognition of MHC-I (Tai et al., 2008).
However, no such effect is observed in vivo in Ly49Q−/− mice,
where a slight reduction in serum levels of IL-12 is observed
in correlation to a moderate increase in viral loads in spleen.
Hence, the biological significance of SiglecH and Ly49Q expres-
sion on pDC for the modulation of their in vivo responses to
viral infections remains an enigma. Finally, during MCMV infec-
tion in vivo, IFN-I inhibits IL-12 production by CD11b+ and
XCR1+ DC (Dalod et al., 2003; Krug et al., 2004; Swiecki et al.,
2010). This might constitute a safeguard mechanism to pre-
vent excessive production of IL-12 and its immunopathological
consequences.
ROLE OF DC SUBSETS IN THE REGULATION OF NK CELL
RESPONSES TO MCMV INFECTION
NK cell responses were first demonstrated to be critical for resis-
tance to MCMV infection more than 30 years ago (Bancroft et al.,
1981; Shellam et al., 1981). A large set of genetically modified
mouse and virus strains allowed a precise understanding of the
interplay between NK cells and MCMV (Miletic et al., 2013).
Here, we will focus on cross-talk between DC and NK cells. More
specifically, we will discuss the contribution of DC subsets to the
cytokine-mediated activation of all NK cells and to the induction
of the proliferation of the subset of NK cells specifically able to
recognize MCMV-infected cells.
ROLE OF DC SUBSETS IN “ASPECIFIC” NK CELL ACQUISITION OF THEIR
ANTIVIRAL EFFECTOR MOLECULAR MACHINERY EARLY AFTER IN VIVO
INFECTION
During MCMV infection, IL-12 promotes NK cell IFN-γ produc-
tion, while IFN-I-induced IL-15 promotes NK cell proliferation,
survival and cytotoxicity (Orange and Biron, 1996b; Nguyen
et al., 2002; Baranek et al., 2012). Since DC are the major source
of IL-12 and IFN-I, they should significantly contribute to the
cytokine-dependent induction of antiviral effector molecules in
NK cells, early after in vivo infection. However, in vivo depletion
of pDC did not dampen NK cell activation but rather enhanced
it, irrespective of the method used [injection of anti-Ly6G (Dalod
et al., 2002) or anti-PDCA-1/Bst2/120G8 antibodies (Krug et al.,
2004) or diphtheria toxin injection in mice transgenic for the
expression of hDTR under the control of the promoter of the
human CLEC4C gene (Swiecki et al., 2010)]. This was correlated
to an exacerbated production of IL-12 by cDC (Dalod et al., 2002;
Krug et al., 2004; Swiecki et al., 2010). Hence, pDC appear to
be dispensable for efficient cytokine-dependent activation of NK
cells in vivo during MCMV infection. This may be due to redun-
dancy between the functions of pDC and those of cDC. NK cells
only express the low avidity receptor for IL-15, IL-15Rβ/γ, while
myeloid cells express the high affinity chain of this receptor, IL-
15Rα. As a result, efficient activation of NK cells by low, physio-
logical, doses of IL-15 requires trans-presentation of the cytokine
on IL-15Rα by myeloid cells (Burkett et al., 2004; Lucas et al.,
2007; Mortier et al., 2008). pDC express only very low levels of the
genes encoding IL-15 and IL-15Rα in MCMV-infected mice, con-
trary to cDC (Baranek et al., 2009, 2012). However, in addition
to cDC, other cell types could contribute to trans-present IL-15
to NK cells, including MoDC, monocytes, macrophages and/or
stromal cells (Mortier et al., 2009; Cui et al., 2014). Hence, the
precise delineation of the role of cDC for cytokine-dependent NK
cell activation during MCMV infection will require investigating
the impact on NK cell responses of the depletion of cDC alone or
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both cDC and pDC. It would also be informative to genetically
inactivate cytokine production specifically in DC subsets.
ROLE OF DC SUBSETS IN THE “COGNATE” NK CELL PROLIFERATION
LATER AFTER IN VIVO INFECTION
C57BL/6 mice are much more resistant to MCMV infection than
BALB/c mice. This is due to a single locus, Cmv1, located in
the NK gene complex which encompasses the genes encoding
the Ly49 activation and inhibitory C-type lectin NK cell recep-
tors (Scalzo et al., 1990). Cmv1 codes for the Ly49H activation
NK cell receptor (Brown et al., 2001; Daniels et al., 2001; Lee
et al., 2001). Ly49H specifically binds an MCMV-encoded pro-
tein, m157, expressed at the surface of infected cells (Arase et al.,
2002; Smith et al., 2002; Bubic et al., 2004). Engagement of Ly49H
by m157 triggers cytotoxic granules exocytosis and is necessary
for NK cell recognition and killing of MCMV-infected cells in
C57BL/6 mice. In addition, engagement of Ly49H by m157 is suf-
ficient to promote the production of IFN-γ and the proliferation
of Ly49H-expressing NK cells in vitro in the absence of NK cell-
activating cytokines (Arase et al., 2002; Smith et al., 2002; Bubic
et al., 2004). In vivo, a specific expansion of Ly49H+ NK cells is
observed at late time points after MCMV infection (Dokun et al.,
2001). It leads to the induction of anti-MCMV NK cell mem-
ory (Sun et al., 2009a), which depends at least in part on the
NK cell-activating cytokines IL-15 and/or IL-12 on the one hand
(Andrews et al., 2003; French et al., 2006; Sun et al., 2009b, 2012;
Firth et al., 2013) and on XCR1+ DC on the other hand (Andrews
et al., 2003). Which cells deliver IL-12 or IL-15 to Ly49H+ NK
cells to promote their specific expansion and how XCR1+ DC
contribute to this function has not been rigorously dissected.
ROLE OF DC SUBSETS IN THE REGULATION OF ANTIVIRAL
CD8 T CELL RESPONSES TO MCMV INFECTION
CD8 T cells significantly contribute to protection against MCMV
infection (Reddehase et al., 1987; Lathbury et al., 1996; Polic
et al., 1998; French et al., 2004, 2005; Mitrovic et al., 2012a).
During acute MCMV infection, all antiviral CD8 T cells rapidly
expand between days 4 and 8 after challenge. After, they undergo
a contraction phase where they give rise to a low number of cen-
tral memory cells which home to secondary lymphoid organs.
After resolution of acute MCMV infection, once latency has been
established, two different behaviors of antiviral CD8 T cells have
been reported. Conventional central memory CD8 T cells self-
maintain at constant levels. Inflationary CD8 T cells continuously
expand over time with a significant fraction harboring an effec-
tor memory phenotype or an effector phenotype (Munks et al.,
2006; Torti et al., 2011b). Inflationary CD8 T cells locate in non-
lymphoid tissues such as the lung or the liver (Karrer et al., 2003;
Torti et al., 2011b). This section will discuss the role of DC sub-
sets in the priming, maintenance and reactivation of conventional
and inflationary anti-MCMV CD8 T cells (Figure 3).
ANTIGEN PRESENTATION BY NON-HEMATOPOIETIC CELLS OR
INFECTED DC IS DISPENSABLE TO PRIME NAÏVE CD8 T CELLS DURING
PRIMARY MCMV INFECTION
Infection of mice with viruses deleted of theMHC-I immune eva-
sion genes m04, m06, and m152 does not affect the magnitude,
repertoire and early kinetics of anti-MCMV CD8 T cell responses
in C57BL/6 mice (Gold et al., 2004; Munks et al., 2007). Hence,
rescuing antigen processing and presentation in infected cells in
vivo does not increase the anti-MCMV CD8 T cell responses
which are already remarkably high in mice infected with WT
viruses. Hence, it was deduced that anti-MCMV CD8 T cells are
not primed by infected cells but rather by cross-presenting cells
which are not affected by viral immune evasion genes. In consis-
tency with this hypothesis, XCR1+ DC isolated from the spleens
of MCMV-infected C57BL/6 mice are not productively infected
by MCMV but efficiently prime naïve anti-MCMV CD8 T cells
ex vivo without the need to add exogenous antigen (Busche et al.,
2013). In contrast, CD11b+ DC isolated from the same mice are
productively infected and fail to activate naïve anti-MCMV CD8
T cells in ex vivo culture, unless they are pulsed with exogenous
optimal epitopic peptides. Hence, productive MCMV infection of
CD11b+ DC in vivo compromises their ability to directly process
and present endogenous antigens to CD8 T cells, including viral
proteins. The priming of anti-MCMV CD8 T cells must depend
onXCR1+ DC cross-presentation of exogenous viral antigens that
they have acquired from neighboring infected cell (Figure 3A).
PROFESSIONAL CROSS-PRESENTING XCR1+ DC ARE NECESSARY FOR
EFFICIENT PRIMING OF NAÏVE ANTI-VIRAL CD8 T CELLS DURING
PRIMARY MCMV INFECTION
By using a spread-defective MCMV mutant which only under-
goes one replication cycle and cannot egress from the first infected
cells, Snyder et al. demonstrated that MCMV-specific CD8 T cells
are efficiently primed in vivo even when infected cells are defi-
cient for MHC-I (Snyder et al., 2010). Hence, cross-presentation
is sufficient to induce normal priming of anti-MCMVCD8 T cells
in vivo. Other approaches demonstrate that cross-presentation is
actually necessary for efficient induction of anti-MCMV CD8 T
cell responses in vivo. Mutant MCMV were engineered to express
both the human papillomavirus E7 and the influenza virus NP
CD8 T cell epitopes, by knock-in into two different regions of the
reporter fluorescent protein GFP: the E7 epitope in the signal pep-
tide which prevents cross-presentation and the NP epitope within
the mature GFP which allows cross-presentation, or reciprocally.
Upon infection of mice with these MCMV mutants, antiviral
CD8 T cells were efficiently generated only against the epitope
that could be well cross-presented, and not against the epitope
that was only presented directly, irrespective of the identity of
these epitopes (E7 or NP). Even with viruses defective for MHC-
I immune evasion genes, no efficient CD8 T cell priming was
observed against antigens that could only be presented directly
(Busche et al., 2013). Finally, the priming of MCMV-specific CD8
T cells is strongly impaired in Batf3-deficient mice, which have
a dramatic and specific decrease in the numbers of professional
cross-presenting XCR1+ DC in all tissues (Torti et al., 2011b).
Altogether, these studies show that cross-presentation is necessary
and sufficient for the induction of antiviral CD8 T cell responses
during MCMV infection in vivo, and that XCR1+ DC are respon-
sible for this function (Figure 3A). Cross-presentation of viral
antigens by uninfected XCR1+ DC is likely necessary for the host
to counter the evasion strategies evolved by the virus to dampen
in infected cells the function of antigen presentation, positive
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FIGURE 3 | Requirements for different antigen-presenting cell types
during acute vs. latent MCMV infection. (A) Professional cross-presenting
XCR1+ cDC are necessary and sufficient for priming of MCMV-specific CD8 T
cell during acute infection. XCR1+ cDC are able to take up and process
antigenic proteins derived from infected cells, either non-hematopoietic cells
as illustrated or the small fraction of infected DC. Once they have processed
viral proteins into epitopic peptides, XCR1+ cDC can present them in
association with MHC-I molecules (signal 1) to anti-MCMV CD8 T cells. The
priming of naïve CD8 T cells for the induction of protective antiviral responses
also requires activating co-stimulation signals (signal 2), such as the
engagement of CD28 on the lymphocytes by CD80/CD86 expressed by the
DC, and activating cytokines (signal 3) such as IL-12 or IFN-I. XCR1+ cDC are
also competent for delivery of signals 2 and 3. Upon priming, naïve
conventional and inflationary CD8 T cells differentiate into effector
conventional and inflationary CD8 T cells, respectively, which control acute
viral replication through recognition and killing of infected cells throughout
the body. (B) Non-hematopoietic cells are necessary to drive inflationary
anti-MCMV CD8 T cell responses during latent infection. After resolution of
acute infection, the compartment of antiviral CD8 T cells contracts and gives
rise to a low number of memory cells. In latent infection, MCMV can
stochastically and transiently reactivate from latently-infected
non-hematopoietic cells, causing the expression and presentation of a small
number of viral antigens. This drives in turn the reactivation and proliferation
of the memory CD8 T cell pool specific for the corresponding viral antigens.
These CD8 T cells acquire an effector/effector-memory phenotype and
expand continuously over time; a process called “memory inflation.” Even
though hematopoietic cells are neither necessary nor sufficient for viral
antigen presentation during latent infection, they might contribute to promote
memory inflation by delivering other signals to CD8 T cells, such as cytokines
or chemokines.
co-stimulation and activating cytokine delivery to CD8 T cells.
However, antigen cross-presentation might not be required in all
organs for local priming of CD8 T cells. Indeed, in the absence
of competent DC, infected liver sinusoidal endothelial cells can
directly prime antiviral CD8 T cells in vitro and in vivo (Kern et al.,
2010). Infected liver sinusoidal endothelial cells may escape the
effects of viral MHC-I and co-stimulation immune evasion genes
because they express immediate-early MCMV genes but poorly
support productive virus replication (Dag et al., 2013).
DURING LATENT MCMV INFECTION, INFLATIONARY MEMORY CD8 T
CELLS ARE MAINTAINED BY LATENTLY INFECTED
NON-HEMATOPOIETIC CELLS
In contrast to the requirement for the priming of naïve anti-
viral CD8 T cells during acute infection, latently infected-non-
hematopoietic cells appear to be the key antigen-presenting cells
driving memory CD8 T cell inflation during latent infection
(Figure 3B). Indeed, professional cross-presenting XCR1+ DC
are not necessary for the inflation of the majority of antiviral
memory CD8 T cells during latency (Torti et al., 2011b). Non-
hematopoietic cells, particularly endothelial cells, are a major
site of MCMV latency. They promote inflationary CD8 T cell
expansion, which is driven by stochastic events of viral reactiva-
tion (Figure 3B) (Simon et al., 2006; Seckert et al., 2009; Arens
et al., 2011). In C57BL/6 mice, long-term expansion and mainte-
nance of H-2Kb-restricted M38-specific CD8 T cells requires H-
2Kb expression by non-hematopoietic cells. Consistently, MCMV
genomes are not detected in hematopoietic cells during latent
infection (Torti et al., 2011a). Similarly, during latent infection
in BALB/c mice, when H-2Ld is expressed only in hematopoietic
cells, H-2Ld-restricted IE1-specific CD8 T cells fail to undergo
inflation, in contrast to H-2Dd-restricted m164-specific CD8
T cells (Seckert et al., 2011). Why the requirements for spe-
cific types of antigen-presenting cells are different during prim-
ing and inflation of MCMV-specific CD8 T cells is still an
open question. One explanation could be that the activation of
naïve T cells requires stronger or more complex signals than
the reactivation of memory or effector T cells. Hence, profes-
sional cross-presenting XCR1+ DC might be needed for prim-
ing because they are the only APC expressing a high enough
density of viral epitope/MHC-I complexes and of activating co-
stimulation molecules, together with a proper cocktail of acti-
vating cytokines (Figure 3A), since they are not subjected to the
inhibitory functions of viral immune evasion genes. Indeed, the
response of naïve and memory conventional anti-MCMV CD8 T
cells, but not the expansion of inflationary CD8 T cells during
early and latent infection, requires a functional B7/CD28 acti-
vating co-stimulation axis (Arens et al., 2011) In contrast, the
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CD70/CD27 co-stimulation pathway promotes enhanced activa-
tion of MCMV-specific CD8 T cells for both conventional and
inflationary responses, during both acute and persistent infec-
tion (Welten et al., 2013). An alternative explanation could be
that professional cross-presenting XCR1+ DC do not access viral
antigens during latent infection, because of stochastic, very low
and extremely transient reactivation of MCMV in immuno-
competent individuals. In any case, it remains possible that
hematopoietic cells could be involved in the maintenance and
expansion of inflationary CD8 T cells during latent infection
through other functions than antigen presentation (Figure 3B).
In particular, they might produce cytokines or chemokines pro-
moting the survival and the proliferation of inflationary CD8 T
cells or their local recruitment at anatomical sites of virus reac-
tivation. Finally, it should be noted that at least one type of
anti-MCMV inflationary CD8 T cell responses, the one directed
against the IE3 viral protein, seems to be dependent on cross-
presentation since it is impaired in Batf3-deficient mice (Torti
et al., 2011b). In summary, the following model can be pro-
posed to explain the inflation of antiviral CD8 T cell responses
during latent infection (Figure 3B). Non-hematopoietic cells
that are infected during acute infection become the main site
of latent MCMV infection. Upon infrequent, stochastic and
very transient episodes of viral gene desilencing, they express
a very restricted repertoire of viral antigens. This leads to the
expansion and maintenance of only those CD8 T cells specific
for the antigens encoded by the viral transcripts expressed in
latency (Seckert et al., 2012). Why are only a few viral epi-
topes driving inflationary CD8 T cells responses? The repertoire
of viral antigens expressed in latently infected cells appears to
be mostly limited to immediate early genes possibly because
these are the first desilenced upon viral reactivation. It is likely
that the rapid recognition of these antigens by effector infla-
tionary CD8 T cells immediately shuts down viral reactiva-
tion, preventing expression of other viral genes during latent
infection in immunocompetent hosts. In favor of this hypoth-
esis, genetic manipulation of MCMV IE1 protein to disrupt
its immunodominant inflationary epitope without affecting its
function leads to an increased detection of IE1 desilencing in
the lungs of latently infected mice, to the induction of events
of IE3 transactivator splicing and to a significant increase in
the frequency of anti-m164 inflationary CD8 T cells (Simon
et al., 2006). Another hypothesis to explain the different anti-
genic repertoire of conventional vs. inflationary anti-MCMVCD8
T cells is a differential usage of proteasome subunits between
inflationary and other viral epitopes. Indeed, mice deficient for
one of the three catalytic subunits of the immunoproteasome
(LMP7) have a reduced number of anti-MCMV CD8 T cells
but with a stronger alteration of the frequency of conventional
as opposed to inflationary antiviral CD8 T cells (Hutchinson
et al., 2011). The immunoproteasome is constitutively expressed
by professional APC, whereas non-immune cells only express
it under the instruction of IFN-γ or IFN-I. Hence, it is possi-
ble that during acute MCMV infection, cross-presenting XCR1+
DC which contain immunoproteasomes and constitutive protea-
somes stimulate responses to both conventional and inflation-
ary epitopes. In contrast, in latent infection, only the epitopes
produced by the constitutive proteasome would be presented by
non-hematopoietic cells.
CROSS-TALK BETWEEN DC AND NK CELLS MODULATE CD8
T CELL RESPONSES DURING MCMV INFECTION
We will now discuss how the cross-talk between DC and NK cells
impacts antiviral CD8 T cell responses (Figure 4).
EFFICIENT NK CELL RESPONSES ACCELERATE THE INDUCTION OF
ANTIVIRAL CD8 T CELL RESPONSES
Mice able to rapidly control MCMV replication though Ly49H-
dependent recognition and killing of infected cells by NK cells
harbor an accelerated priming of naïve CD8 T cells. However,
this response contracts earlier and never reaches the high levels
observed inmice with an inefficient NK cell response (Figure 4A).
Specifically, mice with an efficient NK cell response harbor a
significant number of effector cytotoxic CD8 T lymphocytes
in the spleen as early as 4 days post-infection, 24–48 h earlier
than in Ly49H− congenic animals (Figure 4A) (Robbins et al.,
2007). Different mechanisms could contribute to this process
(Figure 4B). Between days 1.5 and 2 after MCMV infection,
in Ly49H+ mice, NK cells kill infected cells and may provide
to XCR1+ DC faster and increased access to viral antigen for
cross-presentation by delivering them immunogenic apoptotic
bodies (Figure 4B, ➊). NK cells might also promote IL-12 pro-
duction by XCR1+ DC, likewise to the mechanism proposed
for improved induction of anti-tumoral CD8 T cell response in
mice transplanted with NK cell-sensitive as opposed to NK-cell
resistant tumors (Diefenbach et al., 2001; Adam et al., 2005).
As compared to Ly49H− mice, Ly49H+ animals show a strong
decrease in serum levels of innate inflammatory cytokines, such
as pDC-derived type I IFN and IL-12 (Figure 4A), and a better
preservation of the compartment of professional cross-presenting
XCR1+ DC. The induction of high systemic levels of IFN-I
at the time of antiviral CD8 T cell priming by DC might be
counterproductive for the host by negatively impacting the induc-
tion of adaptive cellular immunity. Hence, the early killing of
infected cells by NK cells may reduce the amount of viral ligands
accessible to pDC and thus decrease systemic IFN-I production
(Figure 4B, ➋) to promote the immune activation effects of the
cytokines over their immunosuppressive ones. Yet, it is not clear
whether IFN-I dampen CD8 T cell priming through cell-intrinsic
effects (Figure 4B, ➌) or indirectly by affecting XCR1+ cDC
(Figure 4B, ➍). Both mechanisms might be operating. Indeed,
exogenous injection of IFN-I in Ly49H+ mice recapitulates the
striking delay in anti-MCMV CD8 T cell priming observed in
Ly49H− animals, but only causes a 2-fold decrease in the num-
bers of XCR1+ cDC, suggesting some direct inhibitory effects
of IFN-I on CD8 T cells, as reported in other experimental
models (Bahl et al., 2006; Marshall et al., 2011). However, the
decrease in XCR1+ cDC numbers caused by IFN-I administra-
tion also probably affects the priming of anti-MCMV CD8 T
cells. Low levels of IFN-I may be sufficient to induce an opti-
mal maturation of XCR1+ DC by promoting their induction
of the activating co-stimulation molecules CD40, CD80 and
CD86 but not of the inhibitory co-stimulation molecules PD-
L1 and PD-L2 (Figure 4B, ➎) (Vu Manh et al., 2013). Other
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FIGURE 4 | Schematic model of the cross-talk between XCR1+ DC, NK
cells, and CD8 T cells during MCMV infection. (A) Comparative kinetics
and intensities of innate cytokine, NK and CD8 T cell responses between
mice having or lacking an efficient antiviral NK cell response. (B) Potential
mechanisms in place early after infection of mice with efficient NK cell
responses and promoting accelerated activation of anti-viral CD8 T cells. Early
killing of infected cells may provide XCR1+ DC with a faster and increased
access to viral antigen for cross-presentation by delivering them
immunogenic apoptotic bodies (➊). It may also reduce the amount of viral
ligands accessible to pDC and thus decrease systemic IFN-I production to
promote its immune activation effects over the immunosuppressive ones (➋).
Low IFN-I concentrations may limit the direct negative effects of these
cytokines on CD8 T cells (➌), preserve the maintenance of high numbers of
XCR1+ DC (➍), and promote an optimal maturation of XCR1+ DC by enabling
them to selectively express high levels of activating but not inhibitory
co-stimulatory molecules (➎). (C) Potential mechanisms in place later after
infection of mice with efficient NK cell responses and promoting accelerated
and stronger contraction of anti-viral CD8 T cells. NK cell killing of infected
cells could rapidly shortage the supply of viral antigens available for
cross-presentation by XCR1+ DC (➏). Cognate engagement of Ly49H by
m157 leads to late IL-10 production by the NK cells which limit XCR1+ DC
maturation (➐) and directly inhibit CD8 T cell proliferation (➑).
experimental models were designed to compare anti-MCMV
CD8 T cell responses of mice on the same genetic background but
differing in the ability of their NK cells to control viral replication.
They independently confirmed that efficient NK cell responses
accelerate the induction of anti-MCMV CD8 T cell responses
(Slavuljica et al., 2010; Stadnisky et al., 2011), although differences
were noted depending on the genetic background of the mice in
one study (Slavuljica et al., 2010).
EFFICIENT NK CELL RESPONSES LEAD TO AN EARLIER CONTRACTION
OF ANTIVIRAL CD8 T CELL RESPONSES
Although an efficient NK cell response accelerates the priming of
anti-MCMV CD8 T cells, several reports have shown that it also
leads to an earlier contraction of this cellular adaptive immune
response as early as 6 days post-infection (Figure 4A) (Robbins
et al., 2007; Andrews et al., 2010; Mitrovic et al., 2012a,b). The
sustained and stronger activation of anti-MCMV CD8 T cells
observed in mice lacking efficient antiviral NK cells likely results
from their failure to rapidly control viral replication such that in
vivo expression of viral antigens is prolonged resulting in sus-
tained priming of antiviral CD8 T cells (Andrews et al., 2010;
Mitrovic et al., 2012a). Indeed, starting 4 days after infection,
the total DC isolated from Ly49H− mice prime more naïve CD8
T cells in vitro than the DC isolated from Ly49H+ animals DC
(Andrews et al., 2010). In addition to an earlier shortage in viral
antigen for cross-presentation by XCR1+ DC (Figure 4C, ➏),
other mechanisms could contribute to the faster and stronger
contraction of anti-MCMV CD8 T cells in mice with efficient NK
cell responses. This includes late IL-10 production by the NK cells
that had engaged in cognate interactions with infected cells, since
IL-10 could inhibit the maturation of XCR1+ DC (Figure 4C,➐)
and directly inhibits CD8 T cell proliferation (Figure 4C,➑).
THE CROSS-TALK BETWEEN DC AND NK CELLS MAY ACT AS A
RHEOSTAT MODULATING THE ACTIVATION OF ANTI-VIRAL CD8 T CELL
RESPONSES COMMENSURATE TO THE THREAT CAUSED BY THE LEVEL
OF MCMV REPLICATION.
In mice lacking efficient NK cell responses, strong anti-MCMV
CD8 T cell responses are necessary to allow control of viral
replication and to prevent lethal virus-induced cytopathic dam-
ages to vital organs such as the liver (Lathbury et al., 1996; Lee
et al., 2009; Mitrovic et al., 2012a). In Ly49H+ mice, adaptive
immune responses are necessary to ensure control of virus repli-
cation through different, complementary mechanisms, to avoid
selection of NK cell-escape MCMV mutants (French et al., 2004,
2005). However, much lower levels of CD8 T cell responses are
likely sufficient for this function, while maintenance of strong
effector anti-MCMV CD8 T cell responses might lead to some
immunopathology. Indeed, exacerbated production of TNF and
IFN-γ by anti-MCMV CD8 T cells in the liver of MCMV-
infected mice can induce hepatitis and ultimately cause the
death of the animals (Livingston-Rosanoff et al., 2012). This
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CD8 T cell-dependent immunopathology can be prevented by
immunoregulatory functions of NK cells (IL-10 production) (Lee
et al., 2009) and of activated classical monocytes/MoDC/MDSC
(nitric oxide production) (Daley-Bauer et al., 2012). Hence, both
by controlling the overall viral antigenic load in vivo and by
tuning the functions of DC, NK cells may act as a rheostat
modulating the activation of anti-viral CD8 T cell responses com-
mensurate to the threat caused by the level of MCMV replication,
to promote the level of adaptive immunity sufficient for efficient
control of the virus while limiting immunopathology.
CONCLUSION AND PERSPECTIVES
This review aimed at giving a global overview of the current
knowledge about the interplay between DC and MCMV in vivo,
and how it could be interpreted to learn what makes successful
immune responses against intracellular pathogens. Like all herpes
viruses, MCMV has evolved a plethora of immune evasion genes
including some interfering with DC functions. However, MCMV
infection is inducing one of the most long-lasting and protective
cellular adaptive immune responses known for an intracellular
pathogen. This apparent paradox raises the question of the role
of DC in the induction of protective immunity against MCMV, as
well as whether and how the viral immune evasion genes could
benefit both the host and the virus. The corresponding key issues
we discussed are summarized in Table 2.
Contrary to early reports, it is now quite clear that there
is no induction of global DC functional paralysis by MCMV
in vivo. Additionally, the small fraction of the DC that are infected
by MCMV does not exert a strong dominant immunosuppres-
sive functions in vivo. On the contrary, MCMV infection very
potently activates DC in vivo, in part due to the induction of
high levels of IFN-I which promote DC maturation and their
protective functions against disease and death; and also poten-
tially due to mutually activating interactions between DC and NK
cells. It is likely that this remarkable activation of DC in vivo by
MCMV bears a significant contribution to the balance that has
been reached between this virus and its host during millions of
years of co-evolution. This balance results in a tight control of
Table 2 | Key issues.
MCMV is DNA β-herpes virus establishing life-long persistent infections in mice. It recapitulates many physiopathological characteristics of human
CMV infection.
Dendritic cells (DC) are mononuclear phagocytes involved in both innate and adaptive immunity. They can be divided into two different subsets:
plasmacytoid DC (pDC) and conventional DC (cDC). cDC are constituted by CD11b+ cDC and XCR1+ cDC. XCR1+ cDC are especially efficient in the
activation of CD8 T cells, in particular through cross-presentation.
MCMV infection induces very strong and protective antiviral cellular immune responses in vivo. MCMV induces functional paralysis of DC in vitro but
not in vivo. Several factors can contribute to explain this apparent discrepancy.
• The nature of the DC studied in vitro differs from that of the DC responsible for the induction of anti-MCMV adaptive immune responses in vivo.
• In vitro, most DC are infected, due to the use of very high MOI. Infected DC are unable to efficiently activate antiviral T cells, because of
cell-intrinsic effects of MCMV immune evasion genes. These genes prevent processing and presentation of viral antigens, expression of
activating co-stimulation molecules, and production of activating cytokines.
• In vivo, only a very small fraction of DC is infected. Hence, MCMV immune evasion genes do not strongly modulate overall DC functions in vivo.
• In vivo, the maturation of DC and the acquisition of their protective antiviral functions are promoted by the inflammatory milieu, in particular IFN-I,
and by cross-talk with other immune cells, including NK cells.
In vivo, pDC are the main producers of IFN-I and IL-12, in response to triggering of TLR9 and TLR7 by MCMV-derived nucleic acid sequences.
The production of IFN-I, IL-15, and IL-12 by DC promote NK cell antiviral activity during MCMV infection. For efficient innate control of MCMV infection,
NK cell also require direct recognition of infected cells through the engagement of activating receptors and/or through missing-self sensing.
During acute infection, naïve anti-MCMV CD8 T cells are primed by uninfected professional cross-presenting XCR1+ DC. Cross-presentation of viral
antigens by XCR1+ DC is necessary to counter viral immune evasion strategies. However, in the absence of competent DC, in some tissues,
non-hematopoietic antigen-presenting cells are able to prime naïve CD8 T cells.
The cross-talk between DC, NK cells, and CD8 T cells may act as a rheostat modulating the activation of anti-viral CD8 T cell responses to promote
health over disease. Notably it can prevent irreversible damages to vital tissues as could occur due to either virus cytopathic effects or unbridled host
immune responses.
CMV infection has the extraordinary property to induce strong, long-lasting, protective inflationary effector memory CD8 T cell responses. The
inflation of memory anti-MCMV CD8 T cell responses is driven by recurrent episodes of stochastic and transient viral reactivation in latently infected
non-hematopoietic cells. Viral antigen presentation by DC is neither sufficient nor necessary for this response.
Both cross-presenting XCR1+ DC and virus immune evasion genes play a key role in setting a balance between CMV and their hosts that may benefit
both parties in the absence of developmental, genetic or acquired immunodeficiency of the host.
Owing to its unique ability to induce inflationary memory CD8 T cell responses, CMV has been successfully used as a vector for vaccines against
chronic infections by difficult-to-treat intracellular pathogens in non-human primate disease models.
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both virus replication and host immune responses, which pre-
serves the health of immunocompetent hosts while still allowing
establishment of viral latency and horizontal virus transfer.
The interaction between MCMV and its immunocompetent
natural host, the mouse, appears to be precisely tuned to allow
viral persistence and vertical spread. This includes the establish-
ment of latent infection thanks to viral immune evasion genes,
but no significant morbidity thanks to the host ability to mount
the best suited level of antiviral immunity. On the one hand, host
immune responses are strong enough to control viral replication
in a manner preventing disease development consecutive to viral
cytopathic effects. On the other hand, host immune responses are
tightly controlled to preventing disease development consecutive
to immune-mediated damage to essential organs. Astonishingly,
although pDC are the major producers of IFN-I early after
MCMV infection, they appear to be largely redundant for effi-
cient control of the infection in most organs except in the SG
(Swiecki et al., 2010). SG may play a role in the establishment
of viral latency and constitute the most important site of MCMV
horizontal transfer between hosts. The contribution of pDC to the
control of MCMV latency remains to be investigated but might
be significant since IFN-I plays an important role in this func-
tion (Dag et al., 2014). The delicate balance reached between
MCMV and its host appears to be built on a critical cross-talk
between professional cross-presenting XCR1+ DC and NK cells.
This cross-talk operates as a rheostat to tune the kinetics, intensity
and duration of effector anti-MCMV CD8 T cell responses, com-
mensurate to the threat caused by the level of viral replication.
In this regard, an intriguing question still open is the biolog-
ical significance of the infection of a small fraction of XCR1+
DC by MCMV. An interesting possibility to consider is that it
could promote cross-presentation of MCMV antigens by unin-
fected XCR1+ DC, by allowing their close proximity to infected
cells in adequate micro-anatomical compartments, since infected
and non-infected XCR1+ DC should co-localize in vivo. The
balance reached between MCMV and its host also results from
stochastic and very transient episodes of partial viral reactivation
during persistent latent infection. These reactivation episodes act
as “spontaneous vaccinal boosts” and drive continuous inflation
of protective antiviral effector memory CD8 T cell responses.
Based on many studies discussed in this review, it seems that
the immune evasion functions of MCMV might paradoxically
benefit immunocompetent hosts through different mechanisms:
(i) enhancement of the priming of CD8 T cells, by facilitating
cross-presenting DC physical access to viral antigens, and by lim-
iting the negative feedback caused by the killing of infected cells
(Bohm et al., 2008), (ii) prevention of an exacerbated activa-
tion of CD8 T cells that could lead to severe immunopathology,
(iii) establishment of latent infection leading to the induction of
continuously expanding and long-lasting effector memory CD8
T cells and to a higher state of vigilance of innate immune
cells. These adaptive and innate immune cells might be protec-
tive against virus reactivation from latency (Simon et al., 2006)
and also against secondary infections by some other pathogens
(Barton et al., 2007). This delicate balance between the virus and
the host can be strongly perturbed in individuals with an imma-
ture or compromised immune system, where the functions of the
viral immune evasion genes are not properly counterbalanced
by the host immune responses. Most of these characteristics are
expected to be shared by HCMV infection of humans. It should
not be forgotten that HCMV is the virus the most frequently
transmitted to the developing fetus. Congenital or neonatal infec-
tions often lead to severe morbidity or even to death. In addition,
HCMV is a common opportunistic agent causing severe health
problems in immunocompromised individuals, such as recipi-
ents of bone marrow or solid organ transplants, or AIDS patients.
In these pathological contexts, the immune evasion functions
of HCMV must clearly be deleterious to the host. It is likely
that the functions of XCR1+ cross-presenting DC and their
cross-talk with NK cells are compromised in immunosuppressed
patients, adding up to the deficiencies directly affecting CD8 T
cells and humoral immunity, and contributing to the failure to
control HCMV. In addition to chemotherapeutic inhibition of
the virus and to direct manipulation of antiviral CD8 T cell
responses, treatments should perhaps aim also at rapidly restor-
ing the functions and numbers of XCR1+ DC and NK cells
in immunocompromised patients. This might be achieved by
in vivo administration of FLT3-L and by delivering adequately
adjuvanted HCMV antigens to XCR1+ DC.
In conclusion, CMV infection has the extraordinary prop-
erty to induce strong, long-lasting, protective inflationary effector
memory CD8 T cell responses. One the one hand, this prop-
erty results from the ability of the host to mount strong innate
immune responses to the virus. This involves the activation of
professional cross-presenting DC for priming of CD8 T cells dur-
ing acute infection, in the face of viral immune MHC-I evasion
strategies. On the other hand, this property also results from the
ability of the virus to establish latent infection, despite the power-
ful immune responses of the host, such that multiple episodes of
viral gene desilencing occur throughout the lifetime of the host,
boosting his immune responses. These unique properties of the
interaction between CMVs and their hosts have led to the idea of
using CMV as a vector for vaccines against chronic infections by
difficult-to-treat intracellular pathogens. Several preclinical stud-
ies have been carried out in non-human primates, by vaccinating
monkeys with a rhesus macaque CMV vector coding for proteins
of the Simian Immunodeficiency Virus (SIV) (Hansen et al., 2009,
2011, 2013). Such vaccines are able to protect under prophylactic
settings an important proportion of macaques against primary
infection, by inducing a high frequency of CD4 and CD8 effector
memory T cells able to home in mucosa and to control SIV before
irreversible systemic spread (Hansen et al., 2011). These vaccines
also protect under therapeutic settings, leading to the elimina-
tion of SIV in macaques where systemic viral dissemination had
already occurred. In infectedmacaques therapeutically vaccinated
with a CMV vector expressing SIV antigens, both replicative virus
and proviruses become undetectable in all tissues examined. This
viral clearance takes months to be effective, suggesting that it
occurred through continuous immune surveillance of signs of
SIV reactivation by CMV vaccine-induced inflationary effector
memory T cells. In case of reactivation, these effector memory
CD8 T cells could eliminate immediately the latent cellular reser-
voirs of SIV (Hansen et al., 2013). The new challenge ahead would
be to further advance our knowledge of the interaction between
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CMV and the immune system to design alternative synthetic vac-
cines able to induce such strong and protective responses without
using viral vectors, if ever possible.
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